146 related articles for article (PubMed ID: 24939198)
21. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
22. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
23. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both?
Perkins RB; Stier EA
Ann Intern Med; 2014 Aug; 161(4):295-7. PubMed ID: 24912666
[No Abstract] [Full Text] [Related]
24. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
25. Evaluating a Quality Improvement Program for Cervical Cancer Screening at an Urban Safety Net Clinic.
Hills RL; Kulbok PA; Clark M
Health Promot Pract; 2015 Sep; 16(5):631-41. PubMed ID: 26032371
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
[TBL] [Abstract][Full Text] [Related]
27. Audit of cervical cancer screening and colposcopy attendance in rural South Africa.
Knegt Y
Afr J Reprod Health; 2014 Dec; 18(4):70-8. PubMed ID: 25854095
[TBL] [Abstract][Full Text] [Related]
28. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
29. An assessment of gynecological cytology screening practices among health care providers nationwide.
Darwish-Yassine M; Garvin AD; Johnston CM; Zoschnick L; Conners A; Laing S; Wojcik C
Arch Pathol Lab Med; 2015 May; 139(5):650-5. PubMed ID: 25927148
[TBL] [Abstract][Full Text] [Related]
30. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
31. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
32. [Human papillomavirus testing in cervical cancer screening at a public health service of Santiago, Chile].
Terrazas S; Ibáñez C; Lagos M; Poggi H; Brañes J; Barriga MI; Cartagena J; Núñez F; González F; Cook P; Van De Wyngard V; Ferreccio C
Rev Med Chil; 2015 Jan; 143(1):56-62. PubMed ID: 25860269
[TBL] [Abstract][Full Text] [Related]
33. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
Jensen H; Svanholm H; Støvring H; Bro F
J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
[TBL] [Abstract][Full Text] [Related]
34. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
[TBL] [Abstract][Full Text] [Related]
35. Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.
Yabroff KR; Saraiya M; Meissner HI; Haggstrom DA; Wideroff L; Yuan G; Berkowitz Z; Davis WW; Benard VB; Coughlin SS
Ann Intern Med; 2009 Nov; 151(9):602-11. PubMed ID: 19884621
[TBL] [Abstract][Full Text] [Related]
36. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.
Virtanen A; Anttila A; Luostarinen T; Nieminen P
Int J Cancer; 2011 Jun; 128(11):2681-7. PubMed ID: 20669228
[TBL] [Abstract][Full Text] [Related]
37. Use of electronic medical record-based tools to improve compliance with cervical cancer screening guidelines: effect of an educational intervention on physicians' practice patterns.
White P; Kenton K
J Low Genit Tract Dis; 2013 Apr; 17(2):175-81. PubMed ID: 23343700
[TBL] [Abstract][Full Text] [Related]
38. Point of care testing: can it be a solution for cervical cancer prevention?
Wiwanitkit V
Asian Pac J Cancer Prev; 2010; 11(2):575-6. PubMed ID: 20843156
[TBL] [Abstract][Full Text] [Related]
39. Have the most recent Pap smear guidelines affected GP practices?
Wai D; Ferrier A; Collings S; Laverty C
Aust Fam Physician; 1996 Jan; Suppl 1():S44-8. PubMed ID: 9479800
[TBL] [Abstract][Full Text] [Related]
40. A nurse-led cervical screening clinic in primary care.
Young G
Rev Infirm; 2018 Feb; 67(238):47-48. PubMed ID: 29426562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
